Delivery Order SPE2DB22D2211-SPE2DB25FSEKV
- Not listed
- The Defense Logistics Agency awarded a $21,873.30 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Injectafer 750 mg/15 ml vials. This firm fixed-price, competitively awarded contract is scheduled for completion by August 11, 2025, with performance based in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, indicating AmerisourceBergen competed against other vendors to secure this pharmaceutical supply delivery. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $12,066.50 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This competitive award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials on April 22, 2025, with a ceiling value of $13,894.13 and an ultimate completion date of April 23, 2025. This competitive award, which carries no set-aside designation, is issued under a firm fixed-price contract type. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,239.00 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $13,394.81 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This firm fixed-price, competitively awarded delivery order was issued on June 18, 2025, with an ultimate completion date of June 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a straightforward pharmaceutical procurement to support federal medical supply needs, with no...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 19, 2025, for the supply of Injectafer 750 mg/15 ml vials. The contract has a ceiling value of $10,756.00 and is structured as a firm fixed price delivery order with an ultimate completion date of September 22, 2025. This award was not issued under any set-aside program and was competitively awarded. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,475.68 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This firm fixed-price contract, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a routine pharmaceutical procurement to support federal medical supply needs. The contract is not set-aside and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $6,453.60 from the Defense Logistics Agency (DLA) on June 18, 2025, for the supply of Injectafer 750 mg/15 mL vials. The contract is classified as a child award under a firm fixed-price delivery order arrangement with an ultimate completion date of June 20, 2025. No set-aside designation was applied to this award, indicating it was competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $20,568.01 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This firm fixed price, non-set-aside contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine procurement action within AmerisourceBergen's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of Injectafer 750 mg/15 ml vials. This is a firm fixed price delivery order with a ceiling value of $27,463.25 and an ultimate completion date of September 2, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and was awarded without a set-aside designation, indicating competitive procurement. This...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSEKVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Injectafer 750 mg/15 ml vials valued at $33,246.53 with a firm fixed price structure. This non-competitive, non-set-aside delivery order is set to conclude by September 9, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical distributor supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion comprehensive pharmaceutical support vehicle extending through December 2026. The IDC enables the company to supply a diverse range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and specialized medical commodities. AmerisourceBergen's status as a prime vendor demonstrates its capability to fulfill federal medical supply requirements through competitive procurement processes and underscores its significance in supporting Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.2k | 9/8/25 |